AI and imaging-based cancer screening: getting ready for prime time – Nature Medicine

AI and imaging-based cancer screening: getting ready for prime time – Nature Medicine

Spread the love

New data show that AI could enhance imaging-based screen for pancreatic cancer; however, its evaluation must be rigorous and adhere to the same standards used for conventional screening.

In recent years, artificial intelligence (AI) has become a pervasive element of our lives. Consciously or unconsciously, we interact with AI techniques when using search engines on the internet, posting on or reading social media, or using transportation. In clinical medicine, the uptake of AI has happened at a much slower pace, with diagnoses and treatment recommendations still almost exclusively based on human judgement. Only recently have AI techniques been evaluated for their applicability and potential benefit for several clinical scenarios, with video and imaging applications leading the way1. In this issue of Nature Medicine, Cao et al.2 report the results of a study in which they have assessed AI techniques for detecting and classifying pancreatic lesions in non-contrast computerized tomography (CT) imaging. The approach tries to meet the clinical need for the early detection of pancreatic cancer, a challenging disease given its often unspecific symptoms, which result in late detection and poor prognosis3.

This is a preview of subscription content, access via your institution

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

$29.99 / 30 days

cancel any time

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Fig. 1: AI-assisted prediction and early detection of pancreatic cancer.


  1. Han, R. et al. Preprint at medRxiv (2023).

  2. Cao, K. et al. Nat. Med. (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kleeff, J. et al. Nat. Rev. Dis. Primers 2, 16022 (2016).

    Article  PubMed  Google Scholar 

  4. Lång, K. et al. Lancet Oncol. 24, 936–944 (2023).

    Article  PubMed  Google Scholar 

  5. Ueda, D. et al. Lancet Digital Health 5, e525–e533 (2023).

    Article  CAS  PubMed  Google Scholar 

  6. Zhou, Y. et al. Nature 622, 156–163 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Tadesse, G. F., Tegaw, E. M. & Abdisa, E. K. J. Ultrasound 26, 355–367 (2023).

    Article  PubMed  Google Scholar 

  8. Hon, H. J., Chong, P. P., Choo, H. L. & Khine, P. P. Asian Pac. J. Cancer Prev. 24, 2207–2215 (2023).

    Article  PubMed  Google Scholar 

  9. Zhou, Y., Shi, Y., Lu, W. & Wan, F. Front Psychol. 13, 866124 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Bretthauer, M. et al. JAMA Intern. Med. (2023).

    Article  PubMed  Google Scholar 

  11. Placido, D. et al. Nat. Med. 29, 1113–1122 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kurian, S. J. et al. Mayo Clinic Proc. 95, 2370–2381 (2020).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-Wittenberg, University Medical Center Halle (Saale), Halle (Saale), Germany

    Jörg Kleeff & Ulrich Ronellenfitsch

Corresponding author

Correspondence to Jörg Kleeff.

Ethics declarations

Competing interests

The authors declare that they have no known competing financial or non-financial interests.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kleeff, J., Ronellenfitsch, U. AI and imaging-based cancer screening: getting ready for prime time. Nat Med (2023).

Download citation

  • Published:

  • DOI:

Related News

No Image
No Image
No Image